1. National Institute for Health and Care Excellence. Draft guidance consultation: tixagevimab plus cilgavimab for preventing covid-19. Feb 2023. https://www.nice.org.uk/guidance/indevelopment/gid-ta11102/documents
2. Covid-19: FDA removes US authorisation for antibody drug Evusheld
3. Covid-19: Evusheld protects the most vulnerable patients, analysis shows